Quinet EM[au] - Search Results

Year	Number of Results
1990	2
1992	1
1993	1
1997	1
1999	1
2004	2
2006	2
2008	1
2009	1
2010	2
2023	0

1

Identification of phenylsulfone-substituted quinoxaline (WYE-672) as a tissue selective liver X-receptor (LXR) agonist.

Hu B, Unwalla RJ, Goljer I, Jetter JW, Quinet EM, Berrodin TJ, Basso MD, Feingold IB, Nilsson AG, Wilhelmsson A, Evans MJ, Wrobel JE. Hu B, et al. Among authors: quinet em. J Med Chem. 2010 Apr 22;53(8):3296-304. doi: 10.1021/jm100034x. J Med Chem. 2010. PMID: 20350005

2

Discovery and implementation of transcriptional biomarkers of synthetic LXR agonists in peripheral blood cells.

DiBlasio-Smith EA, Arai M, Quinet EM, Evans MJ, Kornaga T, Basso MD, Chen L, Feingold I, Halpern AR, Liu QY, Nambi P, Savio D, Wang S, Mounts WM, Isler JA, Slager AM, Burczynski ME, Dorner AJ, LaVallie ER. DiBlasio-Smith EA, et al. Among authors: quinet em. J Transl Med. 2008 Oct 16;6:59. doi: 10.1186/1479-5876-6-59. J Transl Med. 2008. PMID: 18925943 Free PMC article. Clinical Trial.

3

Identification of 5α, 6α-epoxycholesterol as a novel modulator of liver X receptor activity.

Berrodin TJ, Shen Q, Quinet EM, Yudt MR, Freedman LP, Nagpal S. Berrodin TJ, et al. Among authors: quinet em. Mol Pharmacol. 2010 Dec;78(6):1046-58. doi: 10.1124/mol.110.065193. Epub 2010 Sep 13. Mol Pharmacol. 2010. PMID: 20837678

4

Modulation of adipose tissue development by pharmacological inhibition of PAI-1.

Crandall DL, Quinet EM, El Ayachi S, Hreha AL, Leik CE, Savio DA, Juhan-Vague I, Alessi MC. Crandall DL, et al. Among authors: quinet em. Arterioscler Thromb Vasc Biol. 2006 Oct;26(10):2209-15. doi: 10.1161/01.ATV.0000235605.51400.9d. Epub 2006 Jul 6. Arterioscler Thromb Vasc Biol. 2006. PMID: 16825598

5

Liver X receptor (LXR)-beta regulation in LXRalpha-deficient mice: implications for therapeutic targeting.

Quinet EM, Savio DA, Halpern AR, Chen L, Schuster GU, Gustafsson JA, Basso MD, Nambi P. Quinet EM, et al. Mol Pharmacol. 2006 Oct;70(4):1340-9. doi: 10.1124/mol.106.022608. Epub 2006 Jul 6. Mol Pharmacol. 2006. PMID: 16825483

6

Design, synthesis, and biological evaluation of thio-containing compounds with serum HDL-cholesterol-elevating properties.

Elokdah H, Sulkowski TS, Abou-Gharbia M, Butera JA, Chai SY, McFarlane GR, McKean ML, Babiak JL, Adelman SJ, Quinet EM. Elokdah H, et al. Among authors: quinet em. J Med Chem. 2004 Jan 29;47(3):681-95. doi: 10.1021/jm030219z. J Med Chem. 2004. PMID: 14736248

7

Synthesis and secretion of plasminogen activator inhibitor-1 by human preadipocytes.

Crandall DL, Quinet EM, Morgan GA, Busler DE, McHendry-Rinde B, Kral JG. Crandall DL, et al. Among authors: quinet em. J Clin Endocrinol Metab. 1999 Sep;84(9):3222-7. doi: 10.1210/jcem.84.9.5987. J Clin Endocrinol Metab. 1999. PMID: 10487691

8

Alternative splicing of the mRNA encoding the human cholesteryl ester transfer protein.

Inazu A, Quinet EM, Wang S, Brown ML, Stevenson S, Barr ML, Moulin P, Tall AR. Inazu A, et al. Among authors: quinet em. Biochemistry. 1992 Mar 3;31(8):2352-8. doi: 10.1021/bi00123a021. Biochemistry. 1992. PMID: 1540591

9

Atherogenic diet increases cholesteryl ester transfer protein messenger RNA levels in rabbit liver.

Quinet EM, Agellon LB, Kroon PA, Marcel YL, Lee YC, Whitlock ME, Tall AR. Quinet EM, et al. J Clin Invest. 1990 Feb;85(2):357-63. doi: 10.1172/JCI114446. J Clin Invest. 1990. PMID: 2298910 Free PMC article.

10

Gene-selective modulation by a synthetic oxysterol ligand of the liver X receptor.

Quinet EM, Savio DA, Halpern AR, Chen L, Miller CP, Nambi P. Quinet EM, et al. J Lipid Res. 2004 Oct;45(10):1929-42. doi: 10.1194/jlr.M400257-JLR200. Epub 2004 Aug 1. J Lipid Res. 2004. PMID: 15292374 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results